Sung Hyun Yang

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Tudor–Eliade Ciuleanu, Thomas Brodowicz, Christoph Zielinski et al. · The Lancet · 2009 · 1.1K citations · Full text

Non-small-cell Lung Cancer, Medicine, Cancer Management +6

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Dong‐Yeop Shin, Im Il Na, Cheol Hyeon Kim et al. · Journal of Thoracic Oncology · 2014 · 318 citations · Full text

Brain Metastasis, Pathology, Bronchial Neoplasm +4

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

Jin Kyung Rho, Yun Jung Choi, Jin Kyung Lee et al. · Lung Cancer · 2008 · 217 citations

Medicine, Egfr Inhibitors, Epithelial-mesenchymal Interactions +7

Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer

Joon Oh Park, Sang‐We Kim, Jin Seok Ahn et al. · Journal of Clinical Oncology · 2007 · 181 citations · Full text

Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy

Won Seog Kim, Seung‐Sook Lee, Baek‐Yeol Ryoo et al. · European Journal of Cancer · 2005 · 159 citations

Lymphoid Neoplasia, Risk-based Stratification, Immunodeficiencies +7